PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract of leaves reduced cell survival and increased apoptosis [PMID:26549816, PMID:27086152]
Extracts and monomeric compounds (kalopanaxsaponin A) showed inhibitory effects in vitro [PMID:40763762]
The lignan derivative DHDA induced neurite outgrowth and enhanced NGF-mediated outgrowth [PMID:16392665]
Evidence summary
PubMed sources
- 1.PMID: 37290493 (2023) — Kalopanax septemlobus: its phytochemistry, pharmacology and toxicity (1966-2022). · Fitoterapia
- 2.PMID: 29186583 (2018) — Transcriptomic Analysis of Kalopanax septemlobus and Characterization of KsBAS, CYP716A94 and CYP72A397 Genes Involved in Hederagenin Saponin Biosynthesis. · Plant & cell physiology
- 3.PMID: 40763762 (2025) — The Antifungal Activity and Potential Mechanism of Kalopanax septemlobus against Trichophyton mentagrophytes and T. rubrum. · Planta medica
- 4.PMID: 22646502 (2012) — Climate oscillation during the Quaternary associated with landscape heterogeneity promoted allopatric lineage divergence of a temperate tree Kalopanax septemlobus (Araliaceae) in East Asia. · Molecular ecology
- 5.PMID: 26549816